SAVACASSAVA SCIENCES INC

Nasdaq cassavasciences.com


$ 10.83 $ -1.02 (-8.65 %)    

Wednesday, 03-Jul-2024 12:59:55 EDT
QQQ $ 491.60 $ -0.14 (-0.03 %)
DIA $ 392.84 $ -0.46 (-0.12 %)
SPY $ 551.46 $ 2.45 (0.45 %)
TLT $ 91.86 $ 1.19 (1.31 %)
GLD $ 219.51 $ 0.00 (0 %)
$ 10.77
$ 11.80
$ 10.76 x 200
$ 10.84 x 100
$ 10.59 - $ 11.93
$ 8.79 - $ 32.10
2,289,254
na
474.98M
$ 1.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-01-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 04-29-2021 03-31-2021 10-Q
14 03-23-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-12-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 03-26-2020 12-31-2019 10-K
19 10-29-2019 09-30-2019 10-Q
20 08-12-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 03-29-2019 12-31-2018 10-K
23 10-30-2018 09-30-2018 10-Q
24 07-26-2018 06-30-2018 10-Q
25 05-09-2018 03-31-2018 10-Q
26 02-06-2018 12-31-2017 10-K
27 11-01-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 04-26-2017 03-31-2017 10-Q
30 03-07-2017 12-31-2016 10-K
31 10-26-2016 09-30-2016 10-Q
32 07-19-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 03-03-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 07-23-2015 06-30-2015 10-Q
37 05-08-2015 03-31-2015 10-Q
38 02-18-2015 12-31-2014 10-K
39 11-05-2014 09-30-2014 10-Q
40 08-06-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cassava-sciences-cooperates-with-doj-sec-on-controversial-alzheimers-drug-investigation

Cassava Sciences is cooperating with DOJ and SEC investigations involving its Alzheimer's drug simufilam. An internal commi...

 jones-trading-downgrades-cassava-sciences-to-hold

Jones Trading analyst Soumit Roy downgrades Cassava Sciences (NASDAQ:SAVA) from Buy to Hold.

 cassava-sciences-engages-with-doj-and-sec-amid-ongoing-investigations-company-board-empowers-ad-hoc-committee-for-internal-investigation-based-on-sec-findings

DOJ Indicts Dr. Hoau-Yan Wang For Allegedly Defrauding NIH With False Research Data; Wang Previously Served As Scientific Advis...

 hc-wainwright--co-downgrades-cassava-sciences-to-neutral

HC Wainwright & Co. analyst Vernon Bernardino downgrades Cassava Sciences (NASDAQ:SAVA) from Buy to Neutral.

 cassava-sciences-issues-statement-on-former-science-advisor-says-dr-wang-and-his-former-public-university-medical-school-have-had-no-involvement-in-the-companys-phase-3-clinical-trials-of-simufilam-simufilam-is-the-companys-lead-drug-candidate-proposed-for-treatment-of-alzheimers-disease

Cassava Sciences, Inc. (NASDAQ:SAVA), reported it has learned today that a federal grand jury returned an indictment charging H...

 cassava-shares-are-down-over-30-heres-why

Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading significantly lower on Friday following the indictment of Hoau-Yan Wan...

 federal-grand-jury-indicts-pennsylvania-man-for-defrauding-nih-of-16m-in-federal-grant-funds-hoau-yan-wang-allegedly-fabricated-scientific-data-in-grant-applications-for-alzheimers-research-charged-with-major-fraud-wire-fraud-and-false-statements-faces-up-to-55-years-in-prison-if-convicted

https://www.justice.gov/opa/pr/professor-charged-operating-multimillion-dollar-grant-fraud-scheme